Disease Management & Health Outcomes

Acknowledgments
pp. 351-352(2)
Author: Adis International Limited

Barrett’s Esophagus: Is Screening and Surveillance Justified?
pp. 353-361(9)
Authors: Deepak V. Gopal; Mark Reichelderfer; Eric A. Gaumnitz; Josephine Harter; Blair A. Jobe

Thiazolidinediones for Diabetes Mellitus: Considerations for Reimbursements by Third-Party Payors
pp. 363-375(13)
Authors: Andrew J. Palmer; William J. Valentine; Joshua A. Ray

Improving Treatment Regimen Adherence in Coronary Heart Disease by Targeting Patient Types
pp. 377-383(7)
Authors: Robin S. Turpin; Jeffrey B. Simmons; Janice F. Lew; Charles M. Alexander; Marie A. Dupee; Patricia Kavanagh; Ellen R. Cameron

Socioeconomic Implications of Long-Term Warfarin Use
pp. 385-392(8)
Authors: Joseph Menzin; Talia Foster; Rebecca Audette

Development of a Regionalized, Comprehensive Care Network for Pediatric Sickle Cell Disease to Improve Access to Care in a Rural State
pp. 393-398(6)
Authors: Lee M. Hilliard; Mary H. Maddox; Shenghui Tang; Thomas H. Howard

Long-Term Drug Treatment of GERD: Economic Issues for Formulary Decision Makers
pp. 399-407(9)
Authors: James Chan; Theodore R. Levin

The Burden of Osteoporosis and the Case for Disease Management
pp. 409-418(10)
Author: William D. Fraser

Effectiveness, Quality of Life, and Cost of Caring for Children in France with Recurrent Acute Rhinopharyngitis Managed by Homeopathic or Non-Homeopathic General Practitioners: A Pragmatic, Prospective Observational Study
pp. 419-427(9)
Authors: Mélanie Trichard; Gilles Chaufferin; Christian Dubreuil; Nicolas Nicoloyannis; Gérard Duru